Trial Profile
The effects of DPP-4 inhibitor on vascular endothelial function in patients with type 2 diabetes mellitus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Jul 2015
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary) ; Glimepiride
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 09 Jul 2015 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 14 Feb 2013 New trial record